Max Healthcare
Stock Snapshot
Price Performance
Vista Outlook
Basis of our Recommendation
Max Healthcare is navigating a complex landscape characterized by aggressive capacity expansion and strategic diversification into medical education. Management's focus on a robust pipeline of over 2,800 beds and the integration of ancillary services like Max@Home and Max Labs is expected to drive long-term revenue growth, despite near-term margin pressures from operational costs and a strategic exit from low-margin oncology segments. Vista's financial outlook anticipates a revenue CAGR of 18% through FY28, supported by strong occupancy rates and a disciplined capital allocation strategy. However, potential regulatory interventions and rising operational costs pose risks to margins. The healthcare sector's growth trajectory remains promising, bolstered by increasing demand for organized healthcare services and expanding insurance coverage. Over the next 12-24 months, key opportunities include the successful integration of new facilities and the ramp-up of high-margin services, while watchpoints include regulatory changes and execution risks associated with the expansion strategy
Why We Like This Stock
- Strong pipeline of over 2,800 beds supports long-term revenue growth
- Diversification into medical education and ancillary services enhances revenue streams
- High occupancy rates and disciplined capital allocation strategy bolster operational resilience
Things To Watch Out For
- Near-term margin pressures due to rising operational costs and exit from low-margin oncology business
- Potential regulatory interventions could impact pricing and profitability
- Execution risks associated with the rapid expansion strategy may affect operational efficiency
Key Parameters
Financial Snapshot
View Technicals Analysis →| Actuals | Forecast | ||||
|---|---|---|---|---|---|
| FY24 | FY25 | FY26 | FY27 | FY28 | |
| Revenue (Cr.) | 5,406 | 7,028 | 8,373 | 8,811 | 10,335 |
| Profit Before Tax (Cr.) | 1,365 | 1,479 | 1,724 | 1,722 | 2,074 |
| PBT Margin | 25.2% | 21.0% | 20.6% | 19.5% | 20.1% |
| Net Profit (Cr.) | 1,094 | 1,126 | 1,506 | 1,503 | 1,810 |
| Earnings Per Share | 11.2 | 11.6 | 15.5 | 15.4 | 18.6 |
Analyst Recommendations
| Broker | Recommendation | Target Price | Date |
|---|---|---|---|
| CLSA | ▲ Outperform | 1,160 | 10-Sep-2026 |
| Anand Rathi | ▲ Buy | 1,220 | 18-Aug-2026 |
| Citigroup | ▲ Buy | 1,240 | 17-Aug-2026 |
| ICICI Securities | ▲ Buy | 1,275 | 17-Aug-2026 |
| JPMorgan | ▲ Overweight | 1,300 | 17-Aug-2026 |
| Jeffries | ▲ Buy | 1,260 | 17-Aug-2026 |
| Kotak Securities | ▼ Sell | 1,015 | 17-Aug-2026 |
| Moneycontrol | ▼ Underweight | nan | 17-Aug-2026 |
| Motilal Oswal | ▲ Buy | 1,410 | 17-Aug-2026 |
| Prabhudas Liladhar | ▲ Buy | 1,150 | 17-Aug-2026 |
| UBS | ▲ Buy | 1,300 | 17-Aug-2026 |
| HSBC | ▲ Buy | 1,125 | 09-Jun-2026 |
| Choice Equity | ► Hold | 1,160 | 03-Jun-2026 |
| HDFC Securities | ► Add | 1,140 | 25-May-2026 |
| Goldman Sachs | ▲ Buy | 1,300 | 13-Apr-2026 |
Company Overview
Show Company Profile
Max Healthcare Institute Limited provides medical and healthcare services in India. It offers services in various specialties, including cardiac sciences, orthopedics, oncology, renal sciences, neurosciences, minimal access and general surgery, pulmonology, obstetrics, bone marrow transplant, bariatric/weight loss surgery, gynecology, minimal access/laparoscopic surgery, eye care/ophthalmology, robotic surgery, paediatrics, nephrology, liver and biliary sciences, gastroenterology and GI surgery, internal medicine, organ transplants, and plastic and reconstructive surgery. The company also provides Max@Home, a platform that offers health and wellness services at home; and Max Lab, which provides diagnostic testing services to patients. In addition, it offers organ and tissue donation, preventive health checks, ambulance and immigration, air ambulance, and insurance and TPA services. The company provides healthcare services through a network of primary care clinics, multi-specialty hospitals/medical centres, and super-specialty hospital facilities. Max Healthcare Institute Limited was incorporated in 2001 and is based in Gurugram, India.